Haha thanks for the tip. I've held CSL for a number of years now, I'll happily hold to see out the Covid issues and see where margins ect land FY24.
My point about Vifor scepticism is that most M&A is value destructive. However, there are some notable reasons why CSL Vifor could do much better under CSL stewardship. Namely the large existing commercialisation network CSL has versus Vifor's much smaller. Vifor is apparently "under commercialised" in terms of reach and products on its books.
Ann: CSL Results Announcement, page-36
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$285.10 |
Change
-6.060(2.08%) |
Mkt cap ! $138.0B | |||
| Open | High | Low | Value | Volume |
| $289.85 | $291.99 | $285.10 | $215.2M | 748.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2976 | $285.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.53 | 75 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |